Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 3Unknown 2Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Breast Neoplasms 42Polycystic Ovary Syndrome 9Advanced Breast Cancer 4Infertility 3Breast Diseases 3Recurrence 2Ovarian Neoplasms 2Neoplasm Metastasis 2Infertility, Female 2is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients. 1Vitamin D Deficiency 1Uterine Cervical Neoplasms 1Solid Tumor 1Pathologic Processes 1Obesity 1Neoplasms 1Myofibroma 1Locally Advanced Breast Cancer 1Hypoxia 1Hydatidiform Mole 1HER2+ Breast Cancer 1Gestational Trophoblastic Disease 1Endometrioid Endometrial Cancer 1Endometrial Neoplasms 1ER Positive, HER2 Negative Breast Cancer 1Carcinoma, Lobular 1Bulbo-Spinal Atrophy, X-Linked 1Breast Cancer Organoids 1Anovulation 1

Interventions

Cyclophosphamide 17fludarabine 13Dexamethasone 12Cisplatin 11Rituximab 10Gemcitabine 9Paclitaxel 7Lenalidomide 7Decitabine 7Cytarabine 7Bendamustine Hydrochloride 7fludarabine phosphate 6N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 6Etoposide 6Carboplatin 6Bortezomib 6Radiotherapy 5Injections 5Azacitidine 5camrelizumab 4apatinib 4Valproic Acid 4Thalidomide 4Procarbazine 4Oxaliplatin 4Drug Therapy 4Antilymphocyte Serum 4tislelizumab 3pomalidomide 3liposomal doxorubicin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Recurrence × Letrozole × Clear all
NCT04666805 2020-12-14

Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast

First Hospital of China Medical University

Unknown
1,354 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Recurrence

NCT02188550 2015-05-19

Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer

Sinai Hospital of Baltimore

Phase 2 Unknown
20 enrolled
Gynecologic

Ovarian Neoplasms, Recurrence, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡